HDAC9 and lung carcinoma: In addition, suppression of lung cancer invasion is perceived in HDAC inhibitor‐repressed MMP‐2/9 activity (Karthik, Sankar, Varunkumar, & Ravikumar, 2014; Liu, Chang, Chiang, & Hung, 2003).